Evidence map›Paper›PMID 29244870›Full record

ArticlePloS one2017

Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.

Lídia Cedó, David Santos, Núria Roglans, Josep Julve, Victor Pallarès, Andrea Rivas-Urbina, Vicenta Llorente-Cortes, Joan Carles Laguna, Francisco Blanco-Vaca, Joan Carles Escolà-Gil

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Lídia CedóInstitut d'Investigacions Biomèdiques (IIB) Sant Pau, Barcelona, Spain.
David SantosInstitut d'Investigacions Biomèdiques (IIB) Sant Pau, Barcelona, Spain.
Núria RoglansDepartment of Pharmacology and Therapeutic Chemistry, School of Pharmacy, University of Barcelona, Barcelona, Spain.
Josep JulveInstitut d'Investigacions Biomèdiques (IIB) Sant Pau, Barcelona, Spain.
Victor PallarèsInstitut d'Investigacions Biomèdiques (IIB) Sant Pau, Barcelona, Spain.
Andrea Rivas-UrbinaInstitut d'Investigacions Biomèdiques (IIB) Sant Pau, Barcelona, Spain.
Vicenta Llorente-CortesLipids and Cardiovascular Pathology Group. CSIC-ICCC-IIB-Sant Pau and Instituto de Investigaciones Biomédicas de Barcelona (IibB)-CSIC, Barcelona, Spain.
Joan Carles LagunaDepartment of Pharmacology and Therapeutic Chemistry, School of Pharmacy, University of Barcelona, Barcelona, Spain.
Francisco Blanco-VacaInstitut d'Investigacions Biomèdiques (IIB) Sant Pau, Barcelona, Spain.
Joan Carles Escolà-GilInstitut d'Investigacions Biomèdiques (IIB) Sant Pau, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9021-2485
Universitat Autònoma de Barcelona · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESUniversitat de Barcelona · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESInstitut d'Investigacions Biomèdiques de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human hepatic lipase (hHL) is mainly localized on the hepatocyte cell surface where it hydrolyzes lipids from remnant lipoproteins and high density lipoproteins and promotes their hepatic selective uptake. Furthermore, hepatic lipase (HL) is closely associated with obesity in multiple studies. Therefore, HL may play a key role on lipid homeostasis in liver and white adipose tissue (WAT). In the present study, we aimed to evaluate the effects of hHL expression on hepatic and white adipose triglyceride metabolism in vivo. Experiments were carried out in hHL transgenic and wild-type mice fed a Western-type diet. Triglyceride metabolism studies included β-oxidation and de novo lipogenesis in liver and WAT, hepatic triglyceride secretion, and adipose lipoprotein lipase (LPL)-mediated free fatty acid (FFA) lipolysis and influx. The expression of hHL promoted hepatic triglyceride accumulation and de novo lipogenesis without affecting triglyceride secretion, and this was associated with an upregulation of Srebf1 as well as the main genes controlling the synthesis of fatty acids. Transgenic mice also exhibited more adiposity and an increased LPL-mediated FFA influx into the WAT without affecting glucose tolerance. Our results demonstrate that hHL promoted hepatic steatosis in mice mainly by upregulating de novo lipogenesis. HL also upregulated WAT LPL and promoted triglyceride-rich lipoprotein hydrolysis and adipose FFA uptake. These data support the important role of hHL in regulating hepatic lipid homeostasis and confirm the broad cardiometabolic role of HL.

Indexed as

Adipose Tissue, WhiteAnimalsDiet, WesternFatty AcidsFatty LiverGene Expression Regulation, EnzymologicGlucoseHumansLipaseLipid MetabolismLipogenesisLipolysisMiceMice, TransgenicObesitySterol Regulatory Element Binding Protein 1Fatty AcidsGlucoseLipaseLIPC protein, humanSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1

Identifiers

PMID29244870
PMCPMC5731695
OpenAlexW2772492123

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.